Browse Category: Therapy

Mikhail Blagosklonny, Bringing Hope to Humanity

Do you like aging or suffering from cancer? I bet you do not. For years now, people have dreaded the idea of aging since we often associate it with death. Also, many diseases that affect humans have had an unbreakable link to old age. Thus, I still do not want to get old. Cancer has been yet another misgiving that has negatively affected the human race for decades. Any efforts directed to finding a lasting cure to the illness have not been fruitful, causing many people to die in its wake. For this reason, individuals like Mikhail Blagosklonny have spent months and years researching on how best to combat the illness. Luckily, Mikhail has had a breakthrough that could revolutionize the diagnosis and treatment of cancer.

Since Mikhail is an educated fellow and a professor at the prestigious Roswell Park Institute, he has not fallen short of a theory to explain his findings. Blagosklonny has come up with the TOR Signaling Theory that tends to prove that Rapamycin can be made use of to slow down aging as well as cure cancer. Initially, the drug was mainly made use of in slowing aging, but Mikhail discovered yet another significant use, that of rejuvenating immunity in the body of a sick person. By stimulating the multiplication of healthy stem cells in the body, Mikhail found Rapamycin ideal in the cure of cancer. Currently speaking, the TOR Signaling Theory is still undergoing scrutiny but proves to hold much ground. Scientists are optimistic about the new breakthrough in health care that originates from a man who has deep knowledge in tumor suppressors, anti-cancer therapeutics, mitosis, apoptosis, and ontogenesis. Based on a rich background in education coupled with years of working experience, Mikhail Blagosklonny has been able to author more than 300 article pieces. His primary point of concern in writing has been in subjects regarding chemotherapeutic engineering, oncology, and cell cyclotherpy.

Besides, Mikhail Blagosklonny has been a significant contributor to the content found in the American Journal of Pathology. As a former employee of the New York Medical College and the Ordway Research Institute, Mikhail has amassed a lot of essential knowledge over the years. Combining with knowledge gained in the fields of Internal Medicine, Cardiology, and Experimental Medicine, Mr. Blagosklonny has become an unbeatable force. Hence, Blagosklonny’s findings come as no surprise to humanity. He is an accurate representation that effort pays. As the TOR Signaling Theory gets tested and proves to hold ground, fewer people will suffer or die from cancer-related illnesses. The human mortality rate will decrease due to reduced aging leading to an overall decline in the wastage of time and money. People will be able to concentrate more on how to be productive thus reducing cases of suffering from illnesses associated with stress and depression. As it turns out, Mikhail Blagosklonny is a real life hero who deserves a Nobel Prize for his good deeds. If it were not for his perseverance, there would never be a light at the end of the tunnel.

The Achievements Of Clay Siegall In The Field Of Cancer Therapy

Clay Siegall is the founder of the reputable Seattle Genetics, which was founded in 1998. He is the acting head, Chief Executive Officer and the Chair of Board governing the company. He acquired a Ph.D. in Genetics from George Washington University and a Bachelor of Science degree in Zoology from the University of Maryland. Dr. Siegall has approximately 20 years of experience in cancer research and therapeutic drug development. The exposure and extensive experience have broadened his knowledge in the field of cancer treatment and he is now a renowned scientist.


Siegall has held several senior positions in various firms include Bristol-Myers Squibb Pharmaceutical Research Institute, the National Cancer Institute and National Institutes of Health. He also serves on the Board of Directors of Alder Bio-Pharmaceuticals and the Washington Biotechnology. His primary concern is research on cancer with the aim of discovering the most effective treatment option. The experience he acquired from these institutions helped him to start up Seattle Genetics Company and manage it effectively to its present status. Besides, he worked with the Board of Governors of the Fred Hutchinson Cancer Research Business Alliance, which actively involves in cancer research projects.


eattle Genetics, under the leadership of Dr. Clay Siegall, has led to the development of antibody-drug conjugates (ADCs) that are used in over 60 countries worldwide for cancer treatment. The effective drug has helped in reducing the suffering of cancer patients. His passion in this field has made him carry out extensive research for further developments.


Due to the massive contribution in scientific and medical communities around the globe, Seagall has received several awards from different institutions. For instance, he has also honored with the Pacific Northwest Ernst & Young Entrepreneur of the Year an award from the University of Maryland in 2012. His passion and natural desire to discover cancer therapy have helped him gain recognition globally.


Dr. Siegall is also an author and has written over 70 articles and research papers. These publications act as the source of information to many scholars across the globe in matters related to cancer and its treatment. Above all, he works with scientists who have passion in his areas of interest. He also holds senior positions on editorial boards involved in editing and publishing scientific journals.